SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-063825
Filing Date
2015-11-09
Accepted
2015-11-09 16:42:15
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q v423042_10q.htm 10-Q 295723
2 EXHIBIT 10.1 v423042_ex10-1.htm EX-10.1 473116
3 EXHIBIT 31.1 v423042_ex31-1.htm EX-31.1 9906
4 EXHIBIT 31.2 v423042_ex31-2.htm EX-31.2 9868
5 EXHIBIT 32.1 v423042_ex32-1.htm EX-32.1 4741
6 EXHIBIT 32.2 v423042_ex32-2.htm EX-32.2 4561
  Complete submission text file 0001144204-15-063825.txt   3365213

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT plx-20150930.xml EX-101.INS 175642
8 XBRL TAXONOMY EXTENSION SCHEMA plx-20150930.xsd EX-101.SCH 58457
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20150930_cal.xml EX-101.CAL 43668
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20150930_def.xml EX-101.DEF 278424
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20150930_lab.xml EX-101.LAB 826220
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20150930_pre.xml EX-101.PRE 447204
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 151216271
SIC: 2836 Biological Products, (No Diagnostic Substances)